| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial and anti-biofilm activities of bio-inspired nanomaterials for wound healing applications
|
Arshad, Rabia
|
|
|
28 |
9 |
p.
|
artikel
|
| 2 |
Artificial intelligence in pharmaceutical regulatory affairs
|
Patil, Ruchika S.
|
|
|
28 |
9 |
p.
|
artikel
|
| 3 |
A systematic review of models of patient engagement in the development and life cycle management of medicines
|
Auwal, F.I.
|
|
|
28 |
9 |
p.
|
artikel
|
| 4 |
Contents page
|
|
|
|
28 |
9 |
p.
|
artikel
|
| 5 |
Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development
|
Yang, Wenzhan
|
|
|
28 |
9 |
p.
|
artikel
|
| 6 |
Degradation of extracellular and membrane proteins in targeted therapy: Status quo and quo vadis
|
Li, Zhenzhen
|
|
|
28 |
9 |
p.
|
artikel
|
| 7 |
Doing science together: Gaining momentum from long-term explorative university–industry research programs
|
Rake, Bastian
|
|
|
28 |
9 |
p.
|
artikel
|
| 8 |
Grasping cryptic binding sites to neutralize drug resistance in the field of anticancer
|
Yang, Wei-Cheng
|
|
|
28 |
9 |
p.
|
artikel
|
| 9 |
How missing value imputation is confounded with batch effects and what you can do about it
|
Goh, Wilson Wen Bin
|
|
|
28 |
9 |
p.
|
artikel
|
| 10 |
Immunotherapy and immunoevasion of colorectal cancer
|
Al Zein, Mohammad
|
|
|
28 |
9 |
p.
|
artikel
|
| 11 |
In silico resources help combat cancer drug resistance mediated by target mutations
|
Huang, Yuan-Qin
|
|
|
28 |
9 |
p.
|
artikel
|
| 12 |
Interactions between modified fullerenes and proteins in cancer nanotechnology
|
Serda, Maciej
|
|
|
28 |
9 |
p.
|
artikel
|
| 13 |
Lactose in tablets: Functionality, critical material attributes, applications, modifications and co-processed excipients
|
Shi, Chuting
|
|
|
28 |
9 |
p.
|
artikel
|
| 14 |
Machine-learning-based adverse drug event prediction from observational health data: A review
|
Denck, Jonas
|
|
|
28 |
9 |
p.
|
artikel
|
| 15 |
Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics
|
Roy, Laboni
|
|
|
28 |
9 |
p.
|
artikel
|
| 16 |
Ocular application of electrospun materials for drug delivery and cellular therapies
|
Mishra, Deepakkumar
|
|
|
28 |
9 |
p.
|
artikel
|
| 17 |
Opportunities and challenges in drug discovery targeting the orphan receptor GPR12
|
Wang, Pingyuan
|
|
|
28 |
9 |
p.
|
artikel
|
| 18 |
Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease
|
Kwa, Faith A.A.
|
|
|
28 |
9 |
p.
|
artikel
|
| 19 |
Recent trends in STING modulators: Structures, mechanisms, and therapeutic potential
|
Zou, Yan
|
|
|
28 |
9 |
p.
|
artikel
|
| 20 |
Repurposing drugs targeting metabolic diseases for cancer therapeutics
|
Pillai U, Jisha
|
|
|
28 |
9 |
p.
|
artikel
|
| 21 |
Targeting inflammatory pathways for treatment of the major depressive disorder
|
Patil, Chandragauda R.
|
|
|
28 |
9 |
p.
|
artikel
|
| 22 |
Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing
|
Li, Dianyang
|
|
|
28 |
9 |
p.
|
artikel
|
| 23 |
Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention
|
Patra, Srimanta
|
|
|
28 |
9 |
p.
|
artikel
|
| 24 |
The dysregulation of lncRNAs by epigenetic factors in human pathologies
|
Zhang, Yanli
|
|
|
28 |
9 |
p.
|
artikel
|
| 25 |
The pharmaceutical innovator’s dilemma
|
Kinch, Michael S.
|
|
|
28 |
9 |
p.
|
artikel
|
| 26 |
Tweaking host immune responses for novel therapeutic approaches against Mycobacterium tuberculosis
|
Roy, Arnab
|
|
|
28 |
9 |
p.
|
artikel
|
| 27 |
UCP1 activation: Hottest target in the thermogenesis pathway to treat obesity using molecules of synthetic and natural origin
|
Jagtap, Utkarsh
|
|
|
28 |
9 |
p.
|
artikel
|
| 28 |
Update on the treatment of cancer cachexia
|
Nishie, Kenichi
|
|
|
28 |
9 |
p.
|
artikel
|
Tijdschrift beschrijving